WINNIPEG, MB, Feb. 22, 2021 /CNW/ - Medicure Inc.
("Medicure" or the "Company") (TSXV: MPH) (OTC: MCUJF), announced
today that it will be participating in Renmark Financial
Communications Inc.'s live Virtual Non-Deal Roadshow Series to
discuss its latest investor presentation on Tuesday, February 23, 2021 at 12:00 PM EST (11:00 PM
CST, 10:00 PM MST). Medicure
welcomes stakeholders, investors, and other individual followers to
register and attend this live event.
The presentation will feature Albert Friesen, Chief Executive Officer &
Chairman of the Board. Topics to be covered will include the latest
investor presentation followed by a live Q&A. Investors
interested in participating in this event will need to register
using the link below. As a reminder, registration for the live
event may be limited but access to the replay after the event will
be on the Company's website (www.medicure.com).
REGISTER HERE:
https://www.renmarkfinancial.com/events/renmark-virtual-non-deal-roadshow-tsx-v-mph/2021-02-23-170000-0
- To ensure smooth connectivity, please access this link
using the latest version of Google Chrome.
About Medicure Inc.
Medicure is a pharmaceutical company focused on the
development and commercialization of therapies for the U.S.
cardiovascular market. The present focus of the Company is the
marketing and distribution of AGGRASTAT® (tirofiban hydrochloride)
injection and ZYPITAMAG® (pitavastatin) tablets in the United States, where they are sold through
the Company's U.S. subsidiary, Medicure Pharma Inc. Medicure also
operates Marley Drug, Inc. ("Marley"), a pharmacy located in
North Carolina that offers an
Extended Supply mail order drug program serving all 50 states,
Washington D.C. and Puerto Rico. Marley is committed to improving
the health status of its patients and the communities they serve
while reducing overall health care costs for employers and other
health care consumers. For more information visit
http://www.marleydrug.com. To learn more about
The Extended Supply Generic Drug Program call 800.286.6781 or
email marleydrug@bellsouth.net. For more
information on Medicure please visit
www.medicure.com. For additional information
about AGGRASTAT®, refer to the full Prescribing
Information. For additional information about
ZYPITAMAG®, refer to the full Prescribing
Information.
About Renmark Financial Communications
Inc.
Founded in 1999, Renmark Financial Communications Inc. is
North America's leading retail
investor relations firm. Employing a strategic and
comprehensive mix of exposure tactics; Renmark hosts Virtual
Non-Deal Roadshows as well as in-person corporate presentations and
maintains daily communications with thousands of brokers and money
managers across Canada and
the United States. Renmark
empowers its publicly-traded clientele to maximize their visibility
within the financial community and strengthen their investor
audience.
View original
content:http://www.prnewswire.com/news-releases/medicure-to-participate-in-renmarks-virtual-non-deal-roadshow-series-on-tuesday-february-23-2021-301232855.html
SOURCE Medicure Inc.